Nanoparticles for providing immune responses against infectious agents
AssigneeMidatech Limited
InventorsThomas William Rademacher, Phillip Williams
Life of this patent
Estimating the term…
Abstract
Nanoparticles for providing immune responses for the treatment or prophylaxis of infection by infectious agents such as viruses, parasites, bacteria, prions and fungi are described which comprises a core including metal and/or semiconductor atoms, wherein the core is covalently linked to a plurality of ligands, the ligands including a carbohydrate residue capable of stimulating an innate immune response, a T cell helper peptide and a danger signal. This platform may then be adapted by including one or more further ligands capable of producing a specific response to a target infectious agent.
Claims5
A method of preparing nanoparticles which comprise a core including metal and/or semiconductor atoms, wherein the core is covalently linked to a plurality of ligands, the ligands including:
- (a) a first ligand comprising a carbohydrate residue capable of stimulating an innate immune response;
- (b) a second ligand comprising a T cell helper peptide;
- (c) a third ligand comprising a danger signal selected from the group consisting of endotoxins, heat-shock proteins, nucleotides, reactive oxygen intermediates, extracellular-matrix breakdown products, neuromediators, cytokines and lipid moieties, wherein said danger signal is a toll-like receptor agonist;
- and
- (d) one or more ligands capable of producing a specific response to a target infectious agent, said nanoparticles further comprising a corona of ligands comprising carbohydrate groups capable of shielding the nanoparticles from recognition by an immune system, so that the immune response produced by the nanoparticles in vivo is specific to the target infectious agent,
- by conjugating one or more of the ligands to the nanoparticle core, the method comprising:
- (i) derivatizing the one or more ligands with a linker;
- and (ii) reacting the linker derivatized ligands with reactants for producing the core of the nanoparticle so that during self-assembly of the nanoparticles, the nanoparticle cores attach to the ligands via the linker.
Dependencies are inferred from the claim text.